Kazunori Morokuma

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

Masanori Isaka, Yoko Yasuda, Masashi Mizokami et al. · Vaccine · 2001 · 77 citations

Medicine, Immunology, Infectious Diseases +17

Clinical Efficacy of Antivenom and Cepharanthine for the Treatment of Mamushi (Gloydius blomhoffii) Bites in Tertiary Care Centers in Japan

Toru Hifumi, Akihiko Yamamoto, Kazunori Morokuma et al. · Japanese Journal of Infectious Diseases · 2013 · 39 citations · Full text

Pharmacy, Pharmacotherapy, Insect Pathology +10

Surveillance of the clinical use of mamushi (Gloydius blomhoffii) antivenom in tertiary care centers in Japan.

Toru Hifumi, Akihiko Yamamoto, Kazunori Morokuma et al. · PubMed · 2011 · 29 citations

Veterinary Medicine, Infectious Diseases, Exotic Animal Medicine +9

Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant

Masanori Isaka, Yoko Yasuda, Tooru Taniguchi et al. · Vaccine · 2003 · 27 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria–pertussis–tetanus (DPT) combination vaccine

Masanori Isaka, Takako Komiya, Motohide Takahashi et al. · Vaccine · 2004 · 26 citations

Life Sciences, Immunology, Infectious Diseases +17